Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients

被引:104
作者
Astaneie, F
Afshari, M
Mojtahedi, A
Mostafalou, S
Zamani, MJ
Larijani, B
Abdollahi, M
机构
[1] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran
关键词
diabetes type 1; oxidative stress; nitric oxide; epidermal growth factor; blood; saliva;
D O I
10.1016/j.arcmed.2005.03.007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. The aim of this study was to examine how type I diabetic patients have altered levels of lipid peroxidation, antioxidant defense, NO and EGF in their plasma and saliva. We tested the differences in lipid peroxidation level, antioxidant power, and concentrations of epidermal growth factor (EGF) and nitric oxide (NO) in saliva and blood of type I diabetic subjects in comparison to healthy control subjects. Methods. Nineteen subjects with type 1 diabetes mellitus and 19 healthy age- and sex-matched control subjects were included in the study. Blood and saliva samples were obtained and analyzed for thiobarbituric reactive substances (TBARS) as a marker of lipid peroxidation, ferric reducing ability (total antioxidant power), EGF and NO levels. Results. TBARS levels did not show a significant difference between the two groups. Analysis of antioxidant power revealed that saliva and plasma of diabetic patients had more antioxidant power (p <0.01) than the healthy control population (107 +/- 10.35 vs. 11.14 +/- 4.66 and 192 +/- 12.3 vs. 142 +/- 15.2 mmol/L, respectively). Concentration of EGF was increased (p <0.01) in saliva whereas it was reduced (p <0.01) in plasma of diabetic patients in comparison to those of healthy subjects (2423 +/- 322 vs. 1513 +/- 341 and 125 +/- 14 vs. 346 +/- 60 pg/mL, respectively). NO level increased in both saliva and plasma of diabetic patients in comparison to those of healthy subjects (46.61 +/- 7 vs. 72.89 +/- 13 and 62.11 +/- 4.6 vs. 76.25 +/- 5 mu mol/L, respectively). Blood HbA1c (%) of patients was significantly higher than that of controls (8.3 +/- 0.32 vs. 5.4 +/- 0.24, p <0.01). Conclusions. Existence of increased total antioxidant power in the presence of normal lipid peroxidation in plasma and saliva of type I diabetic patients indicates the existence of oxidative stress. Increased salivary EGF and NO levels in association with elevated TAOP is interesting and should be further studied. (C) 2005 IMSS. Published by Elsevier Inc.
引用
收藏
页码:376 / 381
页数:6
相关论文
共 48 条
[1]   Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva [J].
Abdollahi, M ;
Fooladian, F ;
Emami, B ;
Zafari, K ;
Bahreini-Moghadam, A .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2003, 22 (11) :587-592
[2]   Stimulation by theophylline and sildenafil of rat submandibular secretion of protein, epidermal growth factor and flow rate [J].
Abdollahi, M ;
Simaiee, B .
PHARMACOLOGICAL RESEARCH, 2003, 48 (05) :445-449
[3]   Increasing intracellular cAMP and cGMP inhibits cadmium-induced oxidative stress in rat submandibular saliva [J].
Abdollahi, M ;
Bahreini-Moghadam, A ;
Emami, B ;
Fooladian, F ;
Zafari, K .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2003, 135 (03) :331-336
[4]   Protection by nitric oxide of morphine-induced inhibition of rat submandibular gland function [J].
Abdollahi, M ;
Safarhamidi, H .
PHARMACOLOGICAL RESEARCH, 2002, 45 (02) :87-92
[5]   Alteration by cadmium of rat submandibular gland secretory function and the role of the L-arginine/nitric oxide pathway [J].
Abdollahi, M ;
Dehpour, A ;
Kazemian, P .
PHARMACOLOGICAL RESEARCH, 2000, 42 (06) :591-597
[6]   L-arginine/nitric oxide pathway and interaction with lead acetate on rat submandibular gland function [J].
Abdollahi, M ;
Dehpour, A ;
Shafayee, F .
PHARMACOLOGY & TOXICOLOGY, 2000, 87 (05) :198-203
[7]  
ABDOLLAHI M, 2001, DARU, V9, P50
[8]  
Abdollahi Mohammad, 2003, J Contemp Dent Pract, V4, P10
[9]   Evaluation of some biochemical changes in diabetic patients [J].
Abou-Seif, MA ;
Youssef, AA .
CLINICA CHIMICA ACTA, 2004, 346 (02) :161-170
[10]   Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes [J].
Astley, S ;
Langrish-Smith, A ;
Southon, S ;
Sampson, M .
DIABETES CARE, 1999, 22 (10) :1626-1631